These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 9265425)

  • 1. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group.
    Raad I; Darouiche R; Dupuis J; Abi-Said D; Gabrielli A; Hachem R; Wall M; Harris R; Jones J; Buzaid A; Robertson C; Shenaq S; Curling P; Burke T; Ericsson C
    Ann Intern Med; 1997 Aug; 127(4):267-74. PubMed ID: 9265425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
    Maki DG; Stolz SM; Wheeler S; Mermel LA
    Ann Intern Med; 1997 Aug; 127(4):257-66. PubMed ID: 9265424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin.
    Raad II; Darouiche RO; Hachem R; Abi-Said D; Safar H; Darnule T; Mansouri M; Morck D
    Crit Care Med; 1998 Feb; 26(2):219-24. PubMed ID: 9468157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use.
    Marciante KD; Veenstra DL; Lipsky BA; Saint S
    Am J Infect Control; 2003 Feb; 31(1):1-8. PubMed ID: 12548250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
    Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
    Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial.
    León C; Ruiz-Santana S; Rello J; de la Torre MV; Vallés J; Alvarez-Lerma F; Sierra R; Saavedra P; Alvarez-Salgado F;
    Intensive Care Med; 2004 Oct; 30(10):1891-9. PubMed ID: 15278273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial.
    Yücel N; Lefering R; Maegele M; Max M; Rossaint R; Koch A; Schwarz R; Korenkov M; Beuth J; Bach A; Schierholz J; Pulverer G; Neugebauer EA
    J Antimicrob Chemother; 2004 Dec; 54(6):1109-15. PubMed ID: 15537696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of catheter-associated bloodstream infection after introduction of minocycline and rifampin antimicrobial-coated catheters in a pediatric burn population.
    Weber JM; Sheridan RL; Fagan S; Ryan CM; Pasternack MS; Tompkins RG
    J Burn Care Res; 2012; 33(4):539-43. PubMed ID: 22210071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study.
    Chatzinikolaou I; Finkel K; Hanna H; Boktour M; Foringer J; Ho T; Raad I
    Am J Med; 2003 Oct; 115(5):352-7. PubMed ID: 14553869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial.
    Hanna H; Benjamin R; Chatzinikolaou I; Alakech B; Richardson D; Mansfield P; Dvorak T; Munsell MF; Darouiche R; Kantarjian H; Raad I
    J Clin Oncol; 2004 Aug; 22(15):3163-71. PubMed ID: 15284269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravascular catheters impregnated with antimicrobial agents: a milestone in the prevention of bloodstream infections.
    Raad I; Hanna H
    Support Care Cancer; 1999 Nov; 7(6):386-90. PubMed ID: 10541979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
    Darouiche RO; Raad II; Heard SO; Thornby JI; Wenker OC; Gabrielli A; Berg J; Khardori N; Hanna H; Hachem R; Harris RL; Mayhall G
    N Engl J Med; 1999 Jan; 340(1):1-8. PubMed ID: 9878638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial.
    Darouiche RO; Berger DH; Khardori N; Robertson CS; Wall MJ; Metzler MH; Shah S; Mansouri MD; Cerra-Stewart C; Versalovic J; Reardon MJ; Raad II
    Ann Surg; 2005 Aug; 242(2):193-200. PubMed ID: 16041209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access.
    Bleyer AJ; Mason L; Russell G; Raad II; Sherertz RJ
    Infect Control Hosp Epidemiol; 2005 Jun; 26(6):520-4. PubMed ID: 16018426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection.
    Abdelkefi A; Achour W; Ben Othman T; Ladeb S; Torjman L; Lakhal A; Ben Hassen A; Hsairi M; Ben Abdeladhim A
    J Support Oncol; 2007 Jun; 5(6):273-8. PubMed ID: 17624052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters.
    Marik PE; Abraham G; Careau P; Varon J; Fromm RE
    Crit Care Med; 1999 Jun; 27(6):1128-31. PubMed ID: 10397217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of silver-coating central venous catheters in reducing bacterial colonization.
    Bach A; Eberhardt H; Frick A; Schmidt H; Böttiger BW; Martin E
    Crit Care Med; 1999 Mar; 27(3):515-21. PubMed ID: 10199530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of using antibiotic-coated peripherally inserted central catheters on decreasing the risk of central line-associated bloodstream infections.
    Yousif A; Chaftari AM; Michael M; Jordan M; Al Hamal Z; Hussain A; Elizabeth N; Jiang Y; Hachem R; Raad I
    Am J Infect Control; 2016 Sep; 44(9):1037-40. PubMed ID: 26897695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial.
    Rupp ME; Lisco SJ; Lipsett PA; Perl TM; Keating K; Civetta JM; Mermel LA; Lee D; Dellinger EP; Donahoe M; Giles D; Pfaller MA; Maki DG; Sherertz R
    Ann Intern Med; 2005 Oct; 143(8):570-80. PubMed ID: 16230723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection.
    Ranucci M; Isgrò G; Giomarelli PP; Pavesi M; Luzzani A; Cattabriga I; Carli M; Giomi P; Compostella A; Digito A; Mangani V; Silvestri V; Mondelli E;
    Crit Care Med; 2003 Jan; 31(1):52-9. PubMed ID: 12544993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.